Literature DB >> 11378493

Physical status of the E2 human papilloma virus 16 viral gene in cervical preneoplastic and neoplastic lesions.

S A Tonon1, M A Picconi, P D Bos, J B Zinovich, J Galuppo, L V Alonio, A R Teyssie.   

Abstract

BACKGROUND: Integration of human papilloma virus (HPV) 16 DNA is considered an important genetic change in cervical lesion progression towards ICC. The viral E2 gene is often disrupted by this process, releasing suppression of viral E6/E7 oncogenes, a key factor for oncogenic progression.
OBJECTIVES: To evaluate the physical status of HPV 16 E2 gene in cervical preneoplastic and neoplastic lesions and its relation with lesion severity. STUDY
DESIGN: A sensitive PCR approach for the detection of an intact E2 HPV 16 gene in infected epithelial cells from the cervix with low grade squamous intraepithelial lesion (LGSIL), high grade squamous intraepithelial lesion (HGSIL) and invasive cervical carcinoma (ICC) diagnosis was applied. The correlation between gene disruption and lesion stage was examined.
RESULTS: Sixty-two LGSIL, 39 HGSIL and 24 ICC samples were analyzed. Fifty-seven LGSIL [92%], 13 HGSIL [33%] and 4 ICC [17%] showed results compatible with an intact E2 gene, while 5 LGSIL [8%], 26 HGSIL [67%] and 20 ICC [83%] samples gave no signal.
CONCLUSIONS: HPV 16 E2 gene disruption showed a positive correlation with cervical lesion progression, particularly from LGSIL to HGSIL. Although additional genetic events are very likely to be needed for HGSIL to ICC progression, the E2 gene disruption is a putative early marker to consider in the prognostic analysis of HPV 16 chronically infected women.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11378493     DOI: 10.1016/s1386-6532(01)00155-x

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  19 in total

1.  HPV16 viral load and physical state measurement as a potential immediate triage strategy for HR-HPV-infected women: a study in 644 women with single HPV16 infections.

Authors:  Anna Manawapat-Klopfer; Lisa Wang; Juliane Haedicke-Jarboui; Frank Stubenrauch; Christian Munk; Louise T Thomsen; Peter Martus; Susanne K Kjaer; Thomas Iftner
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

2.  Physical state and viral load as predictive biomarkersfor persistence and progression of HPV16-positive cervical lesions: results from a population based long-term prospective cohort study.

Authors:  Anna Manawapat; Frank Stubenrauch; Rainer Russ; Christian Munk; Susanne Kruger Kjaer; Thomas Iftner
Journal:  Am J Cancer Res       Date:  2012-02-15       Impact factor: 6.166

3.  Could human papillomaviruses be spread through blood?

Authors:  Sohrab Bodaghi; Lauren V Wood; Gregg Roby; Celia Ryder; Seth M Steinberg; Zhi-Ming Zheng
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

4.  Colorectal papillomavirus infection in patients with colorectal cancer.

Authors:  Sohrab Bodaghi; Koji Yamanegi; Shu-Yuan Xiao; Maria Da Costa; Joel M Palefsky; Zhi-Ming Zheng
Journal:  Clin Cancer Res       Date:  2005-04-15       Impact factor: 12.531

5.  Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response.

Authors:  Mark R Pett; M Trent Herdman; Roger D Palmer; Giles S H Yeo; Mahmud K Shivji; Margaret A Stanley; Nicholas Coleman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

6.  A synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein in mammalian cells and is useful for DNA immunization studies.

Authors:  Angel Cid-Arregui; Victoria Juárez; Harald zur Hausen
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

7.  Methylation of human papillomavirus Type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR.

Authors:  Elise Jacquin; Alice Baraquin; Rajeev Ramanah; Xavier Carcopino; Adrien Morel; Séverine Valmary-Degano; Ignacio G Bravo; Silvia de Sanjosé; Didier Riethmuller; Christiane Mougin; Jean-Luc Prétet
Journal:  J Clin Microbiol       Date:  2013-07-17       Impact factor: 5.948

8.  Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology.

Authors:  S-M A Kulmala; S M Syrjänen; U B Gyllensten; I P Shabalova; N Petrovichev; P Tosi; K J Syrjänen; B C Johansson
Journal:  J Clin Pathol       Date:  2006-02-16       Impact factor: 3.411

9.  Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma.

Authors:  Maëlle Saunier; Sylvain Monnier-Benoit; Frédéric Mauny; Véronique Dalstein; Jenny Briolat; Didier Riethmuller; Bernadette Kantelip; Elisabeth Schwarz; Christiane Mougin; Jean-Luc Prétet
Journal:  J Clin Microbiol       Date:  2008-09-17       Impact factor: 5.948

10.  Sequence variation of human papillomavirus type 16 and measurement of viral integration by quantitative PCR.

Authors:  Mingjun Jiang; Janet G Baseman; Laura A Koutsky; Qinghua Feng; Constance Mao; Nancy B Kiviat; Long Fu Xi
Journal:  J Clin Microbiol       Date:  2008-12-30       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.